Microfluidic GBM Assay Platform With Perfusive Immune Cell Interface

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for glioblastoma multiforme (GBM) are ineffective, and there is a lack of in vitro platforms to study GBM-immune cell interactions, hindering the development of immunotherapies.

Innovation Solution

A microfluidic assay device with a flow channel, reservoirs, and barriers that mimic in vivo conditions, allowing for the study of T-cell interactions with GBM tumor cultures, including endothelial cell-lined channels and hydrogel-encapsulated GBM samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional in vitro platforms are used to study GBM-immune cell interactions, then the platform structure is simple, but the ability to mimic in vivo conditions and study adaptive changes in tumor microenvironment is insufficient

Engineering Contradiction:

Improveability to mimic in vivo conditionsVSAvoidplatform structure

Core Design Contradiction:

Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The microfluidic device is divided into multiple functional segments including a flow channel for immune cell perfusion, a tumor compartment for GBM culture, and an interface region with barriers. This segmentation allows each component to be optimized for its specific function while collectively mimicking the complex in vivo tumor microenvironment, resolving the contradiction between complexity and adaptability.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent introduces an interface region with semipermeable barriers as an intermediary between the flow channel and tumor compartment. This intermediary structure enables controlled cell migration and molecular exchange, allowing the platform to replicate in vivo conditions without requiring complete structural complexity of actual tissue architecture.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Reliability

If a microfluidic device with multiple components (flow channel, reservoirs, barriers) is used to study GBM-immune cell interactions, then the ability to study adaptive changes improves, but the device complexity increases

Engineering Contradiction:

Improvestudy of adaptive changesVSAvoiddevice structure

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The microfluidic device integrates multiple functions into a single platform: it serves as a flow system for immune cell delivery, a culture system for GBM tumors, a migration assay chamber, and a platform for studying adaptive changes. This multi-functionality improves reliability by providing comprehensive study capabilities while avoiding the need for multiple separate complex devices.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent employs semipermeable barriers with controlled porosity at the interface between compartments. These porous structures enable selective cell migration and molecular transport, allowing reliable study of adaptive changes while maintaining a relatively simple device structure compared to fully three-dimensional tissue models.

Inventive Principle:

Principle #31Porous materials

3Adaptability or versatility

If barriers are arranged at the interface to provide semipermeable interface and cell migration, then cell interaction study capability improves, but manufacturing precision requirements increase

Engineering Contradiction:

Improvecell migration capabilityVSAvoidbarrier arrangement precision

Core Design Contradiction:

Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent utilizes changes in barrier parameters (porosity, thickness, material composition) to control cell migration capabilities. By adjusting these parameters during device fabrication, the system achieves versatile cell interaction study capabilities while using standard microfabrication techniques that do not require extreme manufacturing precision.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides a platform for studying GBM-immune cell interactions, enabling a better understanding of adaptive changes in the tumor microenvironment to develop targeted immunotherapies.

Implementation Method 1

a plurality of barriers arranged along the interface of the flow channel with each reservoir; the plurality of barriers configured to provide a semipermeable interface

Methodology Applied

Scientific EffectDiffusion: Diffusion

Implementation Method 2

the plurality of barriers configured to provide a semipermeable interface and/or to provide for cell migration across the interface

Methodology Applied

Scientific EffectFiltration: Filter (physical)

Data Source

PatentUS12502672B2Vascular flow-based microfluidic platform

Publication Date: 2025.12.23 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC

AI summary

Described herein is a microfluidic assay device that mimics in vitro the in vivo biological environment, supporting endothelization, allowing for perfusive flow similar to in vivo blood flow conditions, and providing for realistic interactions between T-cells and solid tumor cells, such as glioblastoma multiforme tumor cells. Also described herein are methods of using this microfluidic assay device for the study of interactions of immune cells with tumor cells, such as glioblastoma multiforme tumor cells, and the development of improved immunotherapeutic approaches against cancers, such as glioblastoma multiforme.